CStone Pharmaceuticals Stock Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
16:25:01 05/10/2026 +03
|
After hours 23:02:56 | |||
| 0.6242 EUR | +0.42% |
|
0.6454 | +3.40% |
| 09-24 | CStone Pharma CEO Buys HK$2.7 Million of Shares | MT |
| 09-07 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| Market Cap | 7.71B 1.15B 1.03B 956M 870M 1.64B 111B 1.65B 11.55B 4.49B 56.53B 4.32B 4.22B 182B | P/E 2026 * |
-16.7x | P/E 2027 * | 4.53x |
|---|---|---|---|---|---|
| Enterprise Value | 6.73B 1B 896M 835M 760M 1.43B 96.71B 1.44B 10.09B 3.92B 49.36B 3.77B 3.69B 159B | EV / Sales 2026 * |
15.9x | EV / Sales 2027 * | 2.14x |
| Free-Float |
79.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
Boerse Muenchen
| PH4 | Real-time | |
Deutsche Boerse AG
| PH4 | Delayed | |
Tradegate
| PH4 | Real-time | |
Börse Stuttgart
| PH4 | Delayed |
Last Transcript: CStone Pharmaceuticals
| 1 day | +0.42% | ||
| 1 week | +7.99% | ||
| Current month | -2.47% | ||
| 1 month | -16.21% | ||
| 3 months | +4.07% | ||
| 6 months | -38.20% | ||
| Current year | +9.51% |
| 1 week | 0.61 | 0.66 | |
| 1 month | 0.55 | 0.67 | |
| Current year | 0.45 | 1.12 | |
| 1 year | 0.45 | 1.12 | |
| 3 years | 0.09 | 1.35 | |
| 5 years | 0.09 | 1.35 | |
| 10 years | 0.09 | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.42% | +7.99% | - | - | 1.15B | ||
| +0.02% | -3.52% | +35.27% | +111.11% | 1,019B | ||
| -1.21% | -6.99% | +34.42% | +60.96% | 617B | ||
| +1.12% | -0.20% | +15.45% | +80.24% | 464B | ||
| -3.30% | -6.15% | +57.14% | +34.69% | 356B | ||
| +0.93% | -3.16% | +21.65% | +43.02% | 333B | ||
| +0.12% | -2.77% | +10.70% | +32.97% | 267B | ||
| -0.89% | -6.28% | -7.00% | +8.01% | 244B | ||
| -0.01% | -3.62% | +37.01% | +52.02% | 218B | ||
| -0.08% | -4.98% | +27.34% | +93.61% | 179B | ||
| Average | -0.49% | -3.54% | +25.78% | +57.40% | 410.8B | |
| Weighted average by Cap. | -0.39% | -3.54% | +28.68% | +68.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 63.11M 56.3M 52.46M 47.74M 89.9M 6.08B 90.56M 634M 247M 3.1B 237M 232M 9.97B | 1.72B 257M 229M 213M 194M 366M 24.74B 369M 2.58B 1B 12.63B 964M 943M 40.59B |
| Net income | -384M -57.21M -51.03M -47.55M -43.27M -81.48M -5.51B -82.09M -574M -224M -2.81B -215M -210M -9.04B | 680M 101M 90.54M 84.35M 76.76M 145M 9.77B 146M 1.02B 397M 4.99B 381M 373M 16.04B |
| Net Debt | -978M -146M -130M -121M -110M -208M -14.04B -209M -1.46B -570M -7.17B -547M -536M -23.04B | -4.02B -600M -535M -499M -454M -855M -57.78B -861M -6.03B -2.34B -29.49B -2.25B -2.2B -94.8B |
| Date | Price | Change |
|---|---|---|
| 05/10/26 | €0.6242 | +0.42% |
| 02/10/26 | €0.6216 | -2.63% |
| 01/10/26 | €0.6384 | -0.25% |
| 30/09/26 | €0.6400 | +4.85% |
| 29/09/26 | €0.6104 | +9.71% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
Select your edition
All financial news and data tailored to specific country editions

















